As mentioned previously, it was apparent that the elevated expression level of Siglec15 relates to adverse prognosis and immune response in glioma patients, and we subsequently elaborated on the effect of Siglec15 in reshaping the tumor microenvironment. This evidence concerns the gene SIGLEC15 and glioma.